Institutional investors purchased a net $3.9 million shares of DXCM during the quarter ended March 2016 and now own 96.61% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 136.9 Thousand shares of DexCom Inc
CIBC WORLD MARKETS, INC. Bought 22.7 Thousand shares of DexCom Inc
SIMPLEX TRADING LLC Bought 20.0 Thousand shares of DexCom Inc